zoladex la 10.8mg implant
astrazeneca ab se-151 85, södertälje, sweden - goserelin - implant - goserelin 10.8 mg - endocrine therapy
nolvadex d 20mg film-coated tablets
astrazeneca ab se-151 85, södertälje, sweden - tamoxifen citrate - film-coated tablet - tamoxifen citrate 20 mg - endocrine therapy
astrazeneca covid-19 vaccine- azd1222 injection, suspension
astrazeneca pharmaceuticals lp - azd-1222 (unii: b5s3k2v0g8) (azd-1222 - unii:b5s3k2v0g8) -
vaxzevria (previously covid-19 vaccine astrazeneca) (chadox1-s) solution for injection multidose vial
astrazeneca pty ltd - chadox1-s, quantity: 100000000000 vp/ml - injection, solution - excipient ingredients: histidine; magnesium chloride hexahydrate; sucrose; disodium edetate; polysorbate 80; sodium chloride; histidine hydrochloride monohydrate; ethanol absolute; water for injections - vaxzevria has provisional approval for the indication:,active immunisation of individuals greater than or equal to 18 years old for the prevention of coronavirus disease 2019 (covid-19) caused by sars-cov-2.,the use of this vaccine should be in accordance with official recommendations.,the decision has been made on the basis of short term efficacy and safety data. continued approval is dependent upon the evidence of longer-term efficacy and safety from ongoing clinical trials and post-market assessment.
bricanyl turbohaler 500 micrograms per metered dose, inhalation powder.
astrazeneca ab se-151 85, södertälje, sweden - inhalation powder - terbutaline sulfate 500 µg/spray - drugs for obstructive airway diseases
bricanyl solution for nebulizing 2.5 mg/ml
astra zeneca-egypt - inhaler - 2.5 mg/ml
imdur 60mg s.r f.c. tab.
astra zeneca-egypt - coated tablet - 60 mg
losec 40mg/ml vial
astra zeneca-egypt - infusion - 40 mg/ml